Sheen T.-SJENG-YUH KOChang Y.-L.2021-11-182021-11-1819980003-4894https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031823807&doi=10.1177%2f000348949810700709&partnerID=40&md5=b19672fff2fd1edca12da226ef110bbehttps://scholars.lib.ntu.edu.tw/handle/123456789/587211Treatment of early glottic cancer is still controversial. A retrospective study was conducted to analyze the results of 49 partial vertical laryngectomies in our department. All patients except 1 were successfully decannulated. The quality of voice was suboptimal but serviceable in all patients. Overall, there were 9 recurrences: 7 in the larynx and 2 in the neck. In the laryngeal recurrence group, 5 of 6 patients were successfully salvaged with total laryngectomy. One patient died of acute renal failure 1 month after salvage operation. Another patient survived 4.5 years after cisplatin-based chemotherapy. In the neck recurrence group, 1 patient was successfully salvaged with neck dissection; the other was lost to follow-up after neck dissection. The actuarial 5-year survival rate was 97.4% and the larynx preservation rate was 88%. The recurrence rate was 14%, when 2 of the 7 laryngeal recurrences were excluded because they occurred beyond 5 years. The results of this series were encouraging. We suggest that partial vertical laryngectomy is a good treatment modality for selected early glottic cancers, especially those of the T1 group.Glottic cancer; Laryngeal cancer; Partial vertical laryngectomy[SDGs]SDG3adult; aged; article; cancer surgery; clinical article; human; laryngectomy; larynx cancer; priority journal; surgical technique; treatment indicationjournal article10.1177/00034894981070070996828552-s2.0-0031823807